Cutting provider reimbursement without addressing the ASP is just the wrong approach.
Editor's note · Context
Bucshon argues against cutting reimbursements without considering drug costs.
Share
More from Larry Bucshon
In closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore (Mr. Edwards). The question is on the motion offered by the gentleman from Indiana (Mr. Bucshon) that the House suspend…
I remind my colleagues that the Democrats control the White House and the Senate. I rise today to discuss once again the Biden administration's foolish rush-to-green agenda over U.S. energy dominance. I support an all-of- the-above energy…
I recognize the legacy of Dr. Michael Burgess and support this bill, H.R. 766. If Members of Congress can agree on one thing, it is that we seek to improve the lives of our constituents. Unfortunately, CBO's current approach to how it…
the national level, one of the things we are trying to determine is, for critical infrastructure, and I mentioned that earlier, that includes pipelines and other things, what is the role of the Federal Government, how do we work with our…





